Search results - 4 results
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: Results of the second data collection (28/09/21-23/02/22)
3 months (but more than 2 weeks ago), the prevalence of anti- SARS-CoV-2 antibodies was 97.9% in the first period of wave 2 (27/09-24/10) and 99.1% in the second period (25/10-21/11). Among the fully ...
Prevalence of Anti-SARS-CoV-2 Antibodies and Potential Determinants among the Belgian Adult Population: Baseline Results of a Prospective Cohort Study
chronic disease (OR a 0.22 (95% CI 0.08–0.62)), having received an mRNA-type vaccine (OR a 5.38 (95% CI 1.72–16.80)), and having received an influenza vaccine in 2020–2021 (OR a 3.79 (95% CI 1.30–11.07)). ...
Prevalence of anti-SARS-CoV-2 antibodies in the general population in Belgium: First results of the SalivaHIS study
community dwelling population aged 18 years and above had developed anti- SARS-CoV-2 antibodies. This percentage was 98.9% among fully vaccinated people (since at least 2 weeks before being tested) and 28.9% ...
Performance of five rapid serological tests in mild-diseased subjects using finger prick blood for exposure assessment to SARS-CoV-2.
sensitivity. At a SARS-CoV-2 prevalence rate of 40%, this RST outperforms the other tests in NPV (96.3%) and reaches comparable PPV (94.9%). Although the specificity of the Covid-Presto is excellent when using ...